
As NCDs continue to burden public health, Chandigarh health dept drive aims 100% screening
Under the National Programme for Prevention and Control of non-communicable diseases (NCDs), the mandate is to ensure 100 per cent screening of all 30 years plus population for diseases like diabetes, hypertension, oral, breast and cervical cancers.
As early identification and action are vital for prevention, the Health Department of Chandigarh is organising population-based and opportunistic screening for individuals above 30 years of age in the health and wellness centres, and other facilities in Chandigarh, with a major footfall for NCD screening seen at the centres, with free tests, medicines and follow-up.
The mass screenings are done as the NCDs are affecting every age group, thereby becoming a major public health concern.
'Apart from NCDs, we also focused on TB and HIV testing. This drive enhanced public awareness and encouraged maximum community outreach, including door-to-door visits of front-line workers to increase coverage,' Dr Suman Singh, director, Health Services, said.
The screening target of hypertension and diabetes was 4,51,030, and the screening achievement was 102.76 per cent for hypertension and 102.89 per cent for diabetes.
'As part of the NCD data calculated till now, as many as 49,130 people, which is 10.6 per cent of the target, were diagnosed as hypertensive, and 31,558 or 6.8 per cent were diagnosed diabetic on screening and have been put on treatment,' Singh shared.
Diabetes has assumed epidemic proportions, with India now known as the diabetes capital of the world. The risk of diabetes is increasing rapidly, even in young people, with many diagnosed between the ages of 20 and 40, Dr Ashu Rastogi, Associate Professor, Department of Endocrinology, PGIMER said.
This is unlike Western countries, where diabetes typically manifests after the age of 60. The reasons for this include a genetic predisposition and lifestyle factors like modern-day stress, a sedentary routine, reliance on fast food, and a lack of regular exercise. 'One in every four new diabetes patients is below 40 years of age. Apart from an unhealthy diet, lack of sleep, and inadequate physical activity are also contributing to the high numbers,' Rastogi added.
Hypertension (HTN) or high blood pressure, explained Rajesh Vijayvergiya, Department of Cardiology at PGIMER, is a term when the individual's blood pressure is more than 140 mmHg systolic and or more than 90 mmHg diastolic blood pressure. For an adult individual, the blood pressure should be less than 140/90mmHg.
'A high prevalence of HTN in urban populations is because of certain unhealthy lifestyles adopted by urbanites, such as lack of physical activity, obesity, increased salt intake by consuming junk and canned foods, and smoking and alcohol consumption, which increase the prevalence of diabetes and increase stress,' Vijayvergiya highlighted.
Most often, HTN does not cause any symptoms and is also known as a silent killer. There are a few symptoms, such as persistent headache, blurring of vision, tiredness, dizziness or spontaneous bleeding from the nose or within the eye, which can suggest underlying high blood pressure.
'Everyone should have his/her blood pressure measured once at the age of 18-20 years, and then to be repeated every 5 years to make an early diagnosis of high blood pressure. Obesity, lack of physical activities/exercise, increased salt and alcohol intake, smoking, high consumption of salt-rich food such as junk and packed foods, pickles, sauces, processed cheese, frozen meals etc, advanced age and genetic susceptibility are a few of the risk factors for HTN,' Vijayvergiya underscored.
The expert added that HTN is one of the major risk factors for cardiovascular diseases such as heart attacks, heart failure, brain strokes, lower limb claudication, loss of vision etc.
'To manage HTN, decrease your body weight to achieve a body mass index (BMI) of less than 25 kg/m2. Good food habits include low salt intake (less than 5 g/day), stop smoking and alcohol consumption; increase intake of fruits, vegetables and pulses; and avoid salt-rich food,' Vijayvergiya recommended.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
6 hours ago
- Time of India
BJ Medical College to undertake ‘targeted' genome sequencing of TB samples to get accurate picture of mutation
1 2 3 Pune: BJ Medical College and Sassoon General Hospital will now undertake 'targeted' genome sequencing of 50 tuberculosis samples. These samples would be sequenced as per World Health Organisation (WHO)'s genome Atlas to analyse the genetic makeup of mycobacterium tuberculosis, the bacterium that causes TB. BJ Medical College is now undertaking 'targeted' genome sequencing of samples from 50 TB patients to get a more accurate picture of mutation in the bacteria. Targeted genome sequencing involves focusing on specific, predefined regions of genome for sequencing, rather than sequencing the entire genome (whole-genome sequencing). This helps researchers and clinicians who want to investigate specific genes or genomic regions of interest. The college had carried out genome sequencing during Covid-19 pandemic. As per WHO, India has the highest burden of TB, with two deaths occurring every three minutes from tuberculosis (TB). Also, India accounts for almost 26% of drug-resistant TB cases from across the world. To expedite TB elimination, the central govt's Dare2eraD TB programme (data driven research to eradicate TB), launched on March 24, 2022 undertook whole genome sequencing of 32,000 TB samples to identify drug resistance and improve treatment outcomes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Adidas Three Shorts With 60% Discount, Limited Stock Available Original Adidas Shop Now Undo As part of this initiative, BJ Medical College had sent 1,000 samples to the department of biotechnology. Dr Rajesh Kartyakarte, head of microbiology department at the college, said, "The central govt's programme entails undertaking whole genome sequencing, which is very time consuming and expensive. However, we are now aiming to focus on targeted 'genome sequencing' for which we will refer to WHO's genome atlas. TB's genome is very big and so it is time consuming but with targeted sequencing we can find the type of mycobacterium and the exact drug resistance. If a particular drug acts on a certain protein and that protein has mutated, it means that the bacteria is resistant to that drug. We have received funding for the same and will soon be able to undertake targeted genome sequencing, maybe in a month or two, once we procure the kits." Dr Sanjay Gaikwad, head of pulmonology department at BJ Medical College, said, "It is very crucial to know whether the patient is suffering from any drug resistance and, if they are, then we need to know from which drug. Based on this information, the drug treatment regime is determined. As of now, we use CBNAAT tests to determine the drug-resistant TB. With the help of this test, we can know whether it is R-resistant or R-sensitive or H-resistant or H-sensitive. " CBNAAT, or cartridge-based nucleic acid amplification test, is a rapid molecular diagnostic test primarily used for diagnosing tuberculosis (TB) and detecting rifampicin resistance, an indicator of MDR-TB. BOX – 28% (28 lakh) of world's TB cases are diagnosed in India every year – 3,31,000 deaths due to TB in the country in 2022 – The Centre's goal is to eliminate TB by 2025 – Drug-resistant TB rate is 7% to 10% Pune: BJ Medical College and Sassoon General Hospital will now undertake 'targeted' genome sequencing of 50 tuberculosis samples. These samples would be sequenced as per World Health Organisation (WHO)'s genome Atlas to analyse the genetic makeup of mycobacterium tuberculosis, the bacterium that causes TB. BJ Medical College is now undertaking 'targeted' genome sequencing of samples from 50 TB patients to get a more accurate picture of mutation in the bacteria. Targeted genome sequencing involves focusing on specific, predefined regions of genome for sequencing, rather than sequencing the entire genome (whole-genome sequencing). This helps researchers and clinicians who want to investigate specific genes or genomic regions of interest. The college had carried out genome sequencing during Covid-19 pandemic. As per WHO, India has the highest burden of TB, with two deaths occurring every three minutes from tuberculosis (TB). Also, India accounts for almost 26% of drug-resistant TB cases from across the world. To expedite TB elimination, the central govt's Dare2eraD TB programme (data driven research to eradicate TB), launched on March 24, 2022 undertook whole genome sequencing of 32,000 TB samples to identify drug resistance and improve treatment outcomes. As part of this initiative, BJ Medical College had sent 1,000 samples to the department of biotechnology. Dr Rajesh Kartyakarte, head of microbiology department at the college, said, "The central govt's programme entails undertaking whole genome sequencing, which is very time consuming and expensive. However, we are now aiming to focus on targeted 'genome sequencing' for which we will refer to WHO's genome atlas. TB's genome is very big and so it is time consuming but with targeted sequencing we can find the type of mycobacterium and the exact drug resistance. If a particular drug acts on a certain protein and that protein has mutated, it means that the bacteria is resistant to that drug. We have received funding for the same and will soon be able to undertake targeted genome sequencing, maybe in a month or two, once we procure the kits." Dr Sanjay Gaikwad, head of pulmonology department at BJ Medical College, said, "It is very crucial to know whether the patient is suffering from any drug resistance and, if they are, then we need to know from which drug. Based on this information, the drug treatment regime is determined. As of now, we use CBNAAT tests to determine the drug-resistant TB. With the help of this test, we can know whether it is R-resistant or R-sensitive or H-resistant or H-sensitive. " CBNAAT, or cartridge-based nucleic acid amplification test, is a rapid molecular diagnostic test primarily used for diagnosing tuberculosis (TB) and detecting rifampicin resistance, an indicator of MDR-TB. BOX – 28% (28 lakh) of world's TB cases are diagnosed in India every year – 3,31,000 deaths due to TB in the country in 2022 – The Centre's goal is to eliminate TB by 2025 – Drug-resistant TB rate is 7% to 10%


Time of India
10 hours ago
- Time of India
Liromoba MLA adopts TB patients, pitches for TB-Free India
Itanagar: Liromoba MLA Pesi Jilen has adopted four TB patients from West Siang district of Arunachal Pradesh under the Ni-Kshay Mitra initiative, part of the Pradhan Mantri TB Mukt Bharat Abhiyan. Speaking at an event held on Saturday at Aalo Zonal Hospital, the MLA encouraged TB patients not to lose hope, emphasising that the disease is curable with proper medication, care, and nutrition. He appealed to all to actively contribute to creating a TB-free India, saying collective effort can bring strength and hope to those battling the illness. He also urged everyone to work together to turn the slogan "TB Haarega, Desh Jeetega" into reality. The MLA also distributed food baskets to seven TB patients. West Siang district medical officer Dr Linya Lollen, Aalo additional deputy commissioner Mabi Taipodia Jini, and district TB officer Dr Nyade Padu Bagra were also present.


Time of India
11 hours ago
- Time of India
Nagaland pledges to be TB-free by 2025, guv reviews progress
Dimapur: Nagaland governor La Ganesan on Monday reviewed the implementation and progress of the state's TB elimination programme. At a review meeting held at Raj Bhavan in Kohima as part of the Pradhan Mantri TB Mukt Bharat Abhiyan, the governor stressed the need to involve religious leaders in raising awareness and reducing the stigma surrounding tuberculosis. The meeting concluded with a collective pledge from all stakeholders to intensify efforts and make Nagaland TB-free by 2025. He also urged people, organisations, and institutions to register as Nikshay Mitras (donors) under the national initiative, aimed at providing nutritional and social support to TB patients — thereby improving treatment outcomes and overall quality of life. Health and family welfare minister Paiwang Konyak briefed the governor on the department's strategies, achievements, and ongoing challenges in the state's fight against TB. He outlined several initiatives to bolster disease surveillance, improve access to care, and increase public awareness — especially in remote and vulnerable areas. Konyak expressed optimism that, with the governor's guidance and support, Nagaland would achieve its targets under the TB Mukt Bharat Abhiyan. Commissioner and secretary for health and family welfare, Anoop Khinchi, also spoke on the department's focus on prevention, early detection, and enhanced patient care. He emphasised the importance of inter-sectoral coordination and strong community engagement, reaffirming the state's alignment with national TB elimination goals.